Patents by Inventor Neil Paulsen

Neil Paulsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230285354
    Abstract: Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
    Type: Application
    Filed: May 12, 2023
    Publication date: September 14, 2023
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Roland Johnson, Michael Kelly, Michael Daniel, Neil Paulsen, Bert Clayton
  • Publication number: 20190142789
    Abstract: Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
    Type: Application
    Filed: August 9, 2018
    Publication date: May 16, 2019
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Roland Johnson, Michael Kelly, Michael Daniel, Neil Paulsen, Bert Clayton
  • Publication number: 20080075759
    Abstract: A palatable, edible soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The edible soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the edible soft chews do not require the use of heat or the addition of water during mixing of active and inactive ingredients, provide stable concentrations of the active ingredient, and produce chews of consistent weight and texture.
    Type: Application
    Filed: November 14, 2007
    Publication date: March 27, 2008
    Applicant: Triad Specialty Products, LLC
    Inventors: Neil Paulsen, Roland Johnson, Michael Coffee
  • Publication number: 20070218050
    Abstract: Methods for treating and preventing middle ear infections by transmembrane administration of medicament-containing transmembrane carrier compositions comprising a chemical penetration enhancer, such as propylene glycol and gluconolactone. The compositions are applied to the ear so as to contact the outer surface of an intact tympanic membrane to deliver the medicament across the membrane and into the middle ear. The medicaments delivered according to the methods of the invention include antibiotic, anti-viral, anti-fungal and anti-inflammatory agents that are useful in treatment and/or prophylaxis of middle ear infections and their sequelae.
    Type: Application
    Filed: February 21, 2007
    Publication date: September 20, 2007
    Inventors: William Campbell, Neil Paulsen, Roland Johnson
  • Publication number: 20070128251
    Abstract: A palatable, soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the soft chews do not require the generation of heat during mixing of active and inactive ingredients, provide stable concentrations of the active ingredient, and produce chews of consistent weight and texture.
    Type: Application
    Filed: December 7, 2005
    Publication date: June 7, 2007
    Inventors: Neil Paulsen, Roland Johnson, Michael Coffee